Skip Nav Destination
Commentary on “Recombinant Humanized Anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts” (A Follow Up)
Cancer Res (2016) 76 (18): 5192–5194.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Mahadeva M. M. Swamy
- Yuta Murai
- Kenji Monde
- Setsuko Tsuboi
- Aravind K. Swamy
- Takashi Jin
ACS Applied Materials & Interfaces (2024) 16 (14): 17253.
- Natasha Tracey
- Helen Creedon
- Alain J. Kemp
- Jayne Culley
- Morwenna Muir
- Teresa Klinowska
- Valerie G. Brunton
Breast Cancer Research and Treatment (2020) 179 (3): 543.
- Rakesh Kumar
- Ferid Murad
- Oliver Bogler
- Bert W. O’Malley
- Gabriel N. Hortobagyi
Genes & Cancer (2019) 10 (5-6): 109.
RSS Feeds